Table 2. Distribution of tumor types in all LFS PV-positive patients (n = 26).
Tumor types diagnosed in PV carriers | Number of tumors per PV group (A/B) | OR (95% CI), p value | Number of patients per group (A/B) | % PV carriers per group (A/B) | Age at diagnosis (range when >1) in each group (A/B) |
---|---|---|---|---|---|
Adrenocortical Carcinoma | 1 / 13 | 16.0 (1.5–875.8), 0.009 | 1 / 13 | 12.5 / 72.2 | 44 / 0 to 17 |
Breast | 8 / 4 | 0.18 (0.03–1.0), 0.03 | 5 / 3 | 62.5 / 16.6 | 21 to 38 / 23 to 57 |
CNS | 2 / 2 | 0.39 (0.02–6.53), 0.56 | 2/ 2 | 25 / 11.1 | 5 to 11 / 1 |
Osteosarcoma | 3 / NA | - | 2 / NA | 25 / NI | 12 to 38 / NA |
Thyroid | 1 / NA | - | 1 / NA | 12.5 / NI | 37 / NA |
DBD, pathogenic variants located in the DNA-binding domain; CNS, Central Nervous System tumors; NA, not applicable; NI, not identified.